Envoy Medical (COCH) FCF Margin (2022 - 2026)
Envoy Medical (COCH) reported FCF Margin of 15541.03% for Q1 2026, down 743016.0% on a YoY basis from N/an in Q1 2025, and down 100.68% sequentially from 7744.0% in Q4 2025.
Envoy Medical (COCH) FCF Margin (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of FCF Margin data on file, last reported at 15541.03% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 743016.0% year-over-year to 15541.03%; the trailing twelve-month figure through Mar 2026 stood at 8850.43% (down 84948.0% YoY), and the FY2025 full-year result was 7626.56%, up 78633.0% from the prior year.
- FCF Margin declined to 15541.03% in Q1 2026, from 7744.0% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1296.25% in Q3 2023 to a low of 15541.03% in Q1 2026.
- A 5-year average of 8271.33% and a median of 8110.87% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 1051222 bps in 2023 and plunged 771589 bps in 2024, its largest moves.
- Tracing COCH's FCF Margin over 5 years: stood at 12100.0% in 2022, then advanced by 3 bps to 11753.68% in 2023, then advanced by 8 bps to 10850.0% in 2024, then increased by 29 bps to 7744.0% in 2025, then plunged by 101 bps to 15541.03% in 2026.
- Business Quant data shows COCH's FCF Margin at 15541.03% in Q1 2026, 7744.0% in Q4 2025, and 10428.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | -1.28% |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 2.18% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 37.67% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 6.68% |
| 10 | Envoy Medical | 45.80 Mn | 20.55 Mn | -274,000.00 | -15,541.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,541.03% |
| Dec 31, 2025 | -7,744.00% |
| Sep 30, 2025 | -10,428.57% |
| Jun 30, 2025 | -5,719.23% |
| Mar 31, 2025 | -8,110.87% |
| Dec 31, 2024 | -10,850.00% |
| Sep 30, 2024 | -6,419.64% |
| Jun 30, 2024 | -7,469.12% |
| Mar 31, 2024 | -9,657.63% |
| Dec 31, 2023 | -11,753.68% |
| Sep 30, 2023 | 1,296.25% |
| Jun 30, 2023 | -6,420.63% |
| Mar 31, 2023 | -3,935.90% |
| Dec 31, 2022 | -12,100.00% |
| Sep 30, 2022 | -9,215.97% |